Detalles de la búsqueda
1.
Adult Umbilical Cord Blood Transplantation Using Myeloablative Thiotepa, Total Body Irradiation, and Fludarabine Conditioning.
Biol Blood Marrow Transplant;
23(11): 1949-1954, 2017 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-28729147
2.
Outcomes of Maintenance Therapy with Bortezomib after Autologous Stem Cell Transplantation for Patients with Multiple Myeloma.
Biol Blood Marrow Transplant;
23(2): 262-268, 2017 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-27856369
3.
Transplantation of Ex Vivo Expanded Umbilical Cord Blood (NiCord) Decreases Early Infection and Hospitalization.
Biol Blood Marrow Transplant;
23(7): 1151-1157, 2017 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-28392378
4.
Reduced-intensity allogeneic transplantation using alemtuzumab from HLA-matched related, unrelated, or haploidentical related donors for patients with hematologic malignancies.
Biol Blood Marrow Transplant;
20(2): 257-63, 2014 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-24269380
5.
Financial Toxicity and Quality of Life in Patients Undergoing Stem-Cell Transplant Evaluation: A Single-Center Analysis.
JCO Oncol Pract;
20(3): 351-360, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38127876
6.
A Phase I study of arsenic trioxide (Trisenox), ascorbic acid, and bortezomib (Velcade) combination therapy in patients with relapsed/refractory multiple myeloma.
Cancer Invest;
31(3): 172-6, 2013 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-23406188
7.
A Phase I Trial of SYK Inhibition with Fostamatinib in the Prevention and Treatment of Chronic Graft-Versus-Host Disease.
Transplant Cell Ther;
29(3): 179.e1-179.e10, 2023 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36577483
8.
Immune recovery in adult patients after myeloablative dual umbilical cord blood, matched sibling, and matched unrelated donor hematopoietic cell transplantation.
Biol Blood Marrow Transplant;
18(11): 1664-1676.e1, 2012 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-22698485
9.
Home-Based Hematopoietic Cell Transplantation in the United States.
Transplant Cell Ther;
28(4): 207.e1-207.e8, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-35066211
10.
Geriatric Assessment Reveals Actionable Impairments in Hematopoietic Stem Cell Transplantation Candidates Age 18 to 80 Years.
Transplant Cell Ther;
28(8): 498.e1-498.e9, 2022 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35595226
11.
Adult dual umbilical cord blood transplantation using myeloablative total body irradiation (1350 cGy) and fludarabine conditioning.
Biol Blood Marrow Transplant;
17(6): 867-74, 2011 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-20868761
12.
Feasibility of low-dose interleukin-2 therapy following T-cell-depleted nonmyeloablative allogeneic hematopoietic stem cell transplantation from HLA-matched or -mismatched family member donors.
Cancer Invest;
29(1): 56-61, 2011 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-21166499
13.
Phase I dose escalation study of naive T-cell depleted donor lymphocyte infusion following allogeneic stem cell transplantation.
Bone Marrow Transplant;
56(1): 137-143, 2021 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32624583
14.
Female Sex Is Associated with Improved Long-Term Survival Following Allogeneic Hematopoietic Stem Cell Transplantation.
Transplant Cell Ther;
27(9): 784.e1-784.e7, 2021 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-34146734
15.
Assessing the Feasibility of a Novel mHealth App in Hematopoietic Stem Cell Transplant Patients.
Transplant Cell Ther;
27(2): 181.e1-181.e9, 2021 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-33830035
16.
Chlorhexidine Gluconate Bathing Reduces the Incidence of Bloodstream Infections in Adults Undergoing Inpatient Hematopoietic Cell Transplantation.
Transplant Cell Ther;
27(3): 262.e1-262.e11, 2021 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-33781532
17.
"Short course" bortezomib plus melphalan and prednisone as induction prior to transplant or as frontline therapy for nontransplant candidates in patients with previously untreated multiple myeloma.
Biol Blood Marrow Transplant;
16(1): 70-7, 2010 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-19733251
18.
Overcoming drug resistance in mantle cell lymphoma using a combination of dose-dense and intense therapy.
Cancer Invest;
28(6): 654-60, 2010 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-20521909
19.
Interrater Reliability of Clinical Grading Measures for Cutaneous Chronic Graft-vs-Host Disease.
JAMA Dermatol;
155(7): 833-837, 2019 07 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30994873
20.
Mini test dose of intravenous busulfan (busulfex(®)) in allogeneic non-myeloablative stem cell transplantation, followed by liquid chromatography tandem-mass spectrometry.
Cancer Invest;
30(9): 679-82, 2012 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-23020519